In a study by Sievert et al, a higher SVR was achieved by patients who were infected with genotype 1 HCV and who developed anemia or decreased hemoglobin levels when treated with Peg-IFN-α-2b + RBV [19]. This evidence concerns the gene IFNA2 and anemia (phenotype).